Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma
- PMID: 15608421
- DOI: 10.1159/000082476
Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma
Abstract
Head and neck squamous cell carcinomas exhibit alterations in cell proliferation, survival (apoptosis), migration, angiogenesis and inflammation. The transcription factor nuclear factor-KappaB integrates multiple signals and regulates expression of multiple genes involved in these phenotypic responses, suggesting the hypothesis that nuclear factor-KappaB is an important molecular switch for development of head and neck squamous cell carcinoma. Nuclear factor-KappaB has been found to be constitutively activated, and a common target and activator of oncogenes in cancer. Because of its important role, activation of nuclear factor-KappaB by the proteasome and other signal molecules may provide targets for molecular therapy of squamous cell carcinoma and other cancers.
Similar articles
-
Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.Head Neck. 2007 Oct;29(10):959-71. doi: 10.1002/hed.20615. Head Neck. 2007. PMID: 17405170 Review.
-
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.Cancer Res. 2006 Aug 15;66(16):8210-8. doi: 10.1158/0008-5472.CAN-06-1213. Cancer Res. 2006. PMID: 16912200
-
Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.Carcinogenesis. 2011 Mar;32(3):368-80. doi: 10.1093/carcin/bgq278. Epub 2010 Dec 22. Carcinogenesis. 2011. PMID: 21177768
-
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.Cancer Res. 2004 Sep 15;64(18):6511-23. doi: 10.1158/0008-5472.CAN-04-0852. Cancer Res. 2004. PMID: 15374962
-
NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.Clin Cancer Res. 2007 Oct 1;13(19):5663-4. doi: 10.1158/1078-0432.CCR-07-1544. Clin Cancer Res. 2007. PMID: 17908953 Review. No abstract available.
Cited by
-
Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor.Mol Cell Biochem. 2011 Jan;346(1-2):125-36. doi: 10.1007/s11010-010-0599-y. Epub 2010 Oct 2. Mol Cell Biochem. 2011. PMID: 20890637
-
Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation.Am J Pathol. 2006 Oct;169(4):1402-14. doi: 10.2353/ajpath.2006.060082. Am J Pathol. 2006. PMID: 17003495 Free PMC article.
-
Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.Br J Cancer. 2019 Feb;120(3):306-316. doi: 10.1038/s41416-018-0351-z. Epub 2018 Dec 26. Br J Cancer. 2019. PMID: 30585254 Free PMC article.
-
Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells.Mol Pharmacol. 2008 Nov;74(5):1215-22. doi: 10.1124/mol.108.049114. Epub 2008 Aug 6. Mol Pharmacol. 2008. PMID: 18684839 Free PMC article.
-
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2.Oncogene. 2016 Jun 2;35(22):2902-12. doi: 10.1038/onc.2015.349. Epub 2015 Sep 28. Oncogene. 2016. PMID: 26411366 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical